EDITORIAL article
Front. Nutr.
Sec. Nutrition and Metabolism
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1631547
This article is part of the Research TopicNutrition and Metabolism in Cancer: Role in Prevention and PrognosisView all 32 articles
EDITORIAL: Nutrition and Metabolism in Cancer: Role in Prevention and Prognosis
Provisionally accepted- 1Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, Italy
- 2Université Clermont Auvergne, Clermont-Ferrand, Auvergne, France
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The involvement of dysmetabolic conditions in cancer has also been demonstrated by Zhang Y. et al. showing the prognostic value of another metabolic marker, the triglycerideglucose index, in non-muscle-invasive bladder cancer. The role of cholesterol in cancer pathogenesis has been extensively demonstrated from a molecular point of view 2 . Here, hyperlipidemia, assessed through the triglycerides-glucose index, has been confirmed by Wang S. et al. as a prognostic factor for patients with newly diagnosed epithelial ovarian cancer. Also the non-high-density lipoprotein to high-density lipoprotein ratio (NHHR) was found strongly associated with all-cause mortality in cancer survivors, by Xie W. et al. who analyzed cancer survivor data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018.Beyond composite scores, individual biochemical markers and inflammatory indicators are also extensively explored for their prognostic value. Serum albumin is repeatedly identified as a crucial marker. Duan R et al. considered age, serum albumin levels, BMI, and activities of daily living (ADL) to propose a new prediction model that demonstrates remarkable accuracy in forecasting malnutrition in elderly hospitalized cancer patients. Lower albumin levels have been linked to frailty measures, trace elements, and inflammation. Inflammatory markers, such as the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Systemic Immune-Inflammation Index (SII), which often combine blood cell counts, are also featured. These indices are suggested to be significant predictive factors for the development of malnutrition in patients with colorectal cancer in the review by Wang X et al. while a preoperative NLR-based prognostic model has been applied by Qi S. to predict the prognosis of intrahepatic cholangiocarcinoma following radical surgery, categorizing patients into different prognostic groups based on NLR cutoffs. The C-reactive protein to albumin ratio (CAR) is proposed as a potentially good prognostic marker in patients undergoing hepatectomy for hepatocellular carcinoma, according to a metaanalysis by Wang S. et al. An Empirical Dietary Inflammatory Pattern (EDIP) with higher inflammatory properties has been found to be associated with increased cancer risk and cancer-specific mortality by Hosseini FS et al. Pro-inflammatory foods include processed meat, red meat, refined grains, and high-energy drinks. Conversely, tomato and pizza showed inverse associations with inflammatory markers in some contexts.However, although obesity may represent a risk factor for cancer development and worse prognosis, on the other hand, malnutrition itself is a significant concern in oncology. Wang J et al. explored the application and validity of the Global Leadership Initiative on Malnutrition (GLIM) 3 criteria in different cancer types and clinical settings, concluding that they appear to require further investigation, particularly in specific populations like East Asian patients with gastric cancer. Conversely, in the context of colorectal cancer patients post-radical surgery, Yan X et al. developed and validated a novel prognostic prediction system based on GLIM-defined malnutrition finding that malnutrition was associated with total complications. A meta-analysis covering studies from 2016 to 2024, primarily from Asia, assessed the Prognostic Nutritional Index (PNI)'s impact on overall survival (OS), recurrence-free survival, and disease-free survival in patients with hepatocellular carcinoma after curative hepatectomy. Intriguingly, Zhang H et al. speculate that hepatocarcinoma (HCC) patients could potentially benefit from preoperative treatments, such as enteral nutrition support or non-steroid anti-inflammatory drugs, to achieve a more favorable PNI value. Furthermore, a higher PNI (suggesting no or mild nutritional risk) was associated with better prognosis compared to severe nutritional risk in prostate cancer patients by Li S-y et al. and as a predictive factor for malnutrition in (colorectal cancer) CRC patients. Nutritional monitoring including physical indicators like weight, percentage weight change, BMI, and grip strength, as well as laboratory indices such as serum albumin, prealbumin, electrolytes, and Creactive protein (CRP) are recommended by Fan X et al. in patients receiving radiotherapy for nasopharyngeal carcinoma. Sarcopenia, characterized by low appendicular lean mass (ALM) and low hand grip strength (HGS), has been associated with an increased risk of HCC in the European population in a Mendelian randomization study by Cao J et al. The association between dietary creatine intake and cancer in US adults has been studied by Jiang J et al., but limitations include potentially lower creatine intake in cancer patients due to recommendations to reduce red meat consumption and the exclusion of non-animal protein sources.In this context, improvement of nutritional strategies in oncology is mandatory. The use of oral nutritional supplements (ONS) to control weight loss in postoperative patients with solid tumors (gastric, colorectal, head and neck, or bladder cancer) has been reviewed by Liu Y et al. and specific dietary factors have been examined for their association with cancer risk or prognosis, although therapeutic controversies over the use of antioxidant supplements during cancer treatment are also reviewed by Woldeselassie M and Tamene A. For instance, a systematic review by Martínez-Domínguez SJ et al. found no association between vitamin C intake (dietary/supplements or circulating levels) and pancreatic cancer risk, suggesting no specific recommendation for high vitamin C intake for this purpose is needed while a more recent meta-analysis by Ni Y-J et al. on the association between dietary antioxidant vitamins (A, C, E) and glioma risk found that higher intake of vitamin C significantly reduced glioma risk, while no significant associations were observed for vitamin A or E.In conclusion, this topic offers a multifaceted view of the relationship between nutrition and cancer, underscoring the predictive value of various nutritional and body composition markers, examining the effectiveness of different forms of nutritional support, and analyzing the impact of dietary patterns and specific nutrients on cancer risk and prognosis. They also highlight the methodological challenges in nutritional oncology research and the need for further high-quality studies to strengthen the evidence base.
Keywords: Cholesterol, Hepatocellar carcinoma, Obesity, Adipose Tissue, Metaboli c pathway
Received: 19 May 2025; Accepted: 29 May 2025.
Copyright: © 2025 Crudele, MOSCHETTA and Lobaccaro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Antonio MOSCHETTA, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.